Judy Faulkner: Profitability Is a ‘Side Effect,’ Not the Goal

Why It Matters

Epic’s non‑profit‑driven model demonstrates that a large‑scale health‑tech firm can thrive without public‑market pressures, influencing industry standards for patient outcomes and cost control. Its governance structure also sets a precedent for founder‑led stewardship in critical infrastructure sectors.

Key Takeaways

• Epic's 2025 revenue reaches $6.7 B while staying privately owned
• Faulkner calls profit a side effect, not the primary goal
• Voting shares will transfer to a family‑run trust after her death
• Epic holds over 40% of U.S. hospital EHR market
• Faulkner donates ~$100 M annually to Roots & Wings foundation

Pulse Analysis

Epic’s decision to remain privately held gives it a rare degree of strategic freedom in the highly regulated health‑tech arena. Without the quarterly earnings pressure of public markets, the company can invest heavily in long‑term product innovation and customer support, fostering deep integrations that lock hospitals into its ecosystem. This autonomy also shields Epic from activist shareholders demanding short‑term returns, allowing Faulkner to keep the focus on patient care and system reliability rather than margin expansion.

The governance plan Faulkner outlined—transferring voting shares to a trust overseen by her family and senior managers—ensures continuity of the mission‑first philosophy beyond her tenure. By legally binding the company’s leadership to her vision, Epic can resist takeover bids and maintain its pricing discipline, which many health systems cite as a factor in keeping overall healthcare IT spend in check. The trust structure also provides a clear succession path, reducing uncertainty for the 40%+ of U.S. hospitals that rely on Epic’s electronic health record platform.

From an industry perspective, Epic’s model challenges the conventional wisdom that scale and profitability require public capital. Its ability to generate $6.7 billion in revenue, sustain a low litigation rate, and donate roughly $100 million annually to the Roots & Wings foundation illustrates a sustainable, purpose‑driven business at scale. As other health‑tech firms grapple with investor demands and regulatory scrutiny, Epic’s example may inspire a reevaluation of ownership structures that balance financial health with broader societal impact.